Sanara MedTech Inc. (NASDAQ:SMTI) Director S Oden Howell, Jr. acquired 60,241 shares of Sanara MedTech stock in a transaction on Tuesday, October 15th. The shares were bought at an average cost of $11.00 per share, with a total value of $662,651.00.
SMTI opened at $12.20 on Wednesday. Sanara MedTech Inc. has a 52 week low of $2.00 and a 52 week high of $12.20.
Sanara MedTech (NASDAQ:SMTI) last released its earnings results on Wednesday, August 14th. The company reported ($0.15) earnings per share (EPS) for the quarter. The business had revenue of $3.02 million during the quarter.
Sanara MedTech Inc develops, markets, and distributes biotechnology products to physicians, hospitals, and clinics in the United States. It offers HemaQuell, a resorbable bone hemostat for bone healing; and CellerateRX surgical for healing. The company was formerly known as WNDM Medical Inc and changed its name to Sanara MedTech Inc in May 2019.
Read More: Bollinger Bands
Receive News & Ratings for Sanara MedTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanara MedTech and related companies with MarketBeat.com's FREE daily email newsletter.